Akshat Jain/Loma Linda University Health
Feb 28, 2026, 16:25
Akshat Jain: Elevating Equity in Diagnosis, Care, and Research on World Rare Disease Day 2026
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared on LinkedIn:
”Today is World Rare Disease Day 2026 — a moment to champion equity in diagnosis, care, and research for the 300 million people living with rare conditions.
This year’s theme, ‘Elevate Equity in Every Action’, reminds us that policy, science, and clinical practice must include rare disease voices from the start.
How is your organization working to close these gaps?
Prevention and Diagnosis :
- Accessible (virtual or live) Genetic Counselling
- Global NewBorn Testing
- Affordable Genome sequencing
- Speciality trained workforce
RandD, Therapies:
- Novel Therapeutics in RD
- Scale up access to transformative therapies to meet global demand
- Cost Equity in Gene Therapy”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 14:16Hyperfibrinolysis as an Underrecognized Cause of Bleeding
-
Oct 19, 2026, 13:36Shobhna Ladva: Aspen Pharma EME Raises Awareness of Blood Clot Risks During Hormonal Transitions
-
Oct 19, 2026, 13:11Giulia Furnari: Connecting With Global Hematology Experts at IACH 2026
-
Oct 19, 2026, 12:46Andrew Choong: Recognizing Thrombosis Before It Becomes Life-Threatening
-
Oct 19, 2026, 11:37Beth Faiman: APSHO Fellows Celebrated for Advancing Hematology and Oncology Practice
-
Oct 19, 2026, 11:26Emanuele Pacini: Myelodysplastic Syndromes Research Featured at JSH Annual Meeting in Kyoto
-
Oct 19, 2026, 10:57Jesmond Dalli: How Erythroblasts Shape Neutrophil Development and Function
-
Oct 19, 2026, 10:41Hisham Fahmi: SCD – Should Gene Editing Begin Before Organ Damage?
-
Oct 19, 2026, 10:33Pallavi Madhiraju: YARTEMLEA Faces Another European Rejection Despite FDA Approval